Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00143754
Recruitment Status : Terminated
First Posted : September 2, 2005
Last Update Posted : September 2, 2005
Information provided by:
University Hospital, Angers

Brief Summary:
Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.

Condition or disease Intervention/treatment Phase
Hydration Loss of Consciousness Neurocardiogenic Syncope Procedure: Hydration Phase 3

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Benefit of Controlled Rehydration in Unexplained Syncope

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fainting
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Syncopal and/or near syncopal episodes at least twice within the prior 3 months

Exclusion Criteria:

  • Neurological disease
  • Structural heart disease
  • Metabolic and psychiatric illness

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00143754

Sponsors and Collaborators
University Hospital, Angers
Principal Investigator: Georges PN Leftheriotis, MD-PhD HUAngers Identifier: NCT00143754     History of Changes
Other Study ID Numbers: CP00-02
Centre Evian pour l'Eau
First Posted: September 2, 2005    Key Record Dates
Last Update Posted: September 2, 2005
Last Verified: August 2005

Additional relevant MeSH terms:
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms